419 studies found for:    "neuroblastoma"
Show Display Options
Rank Status Study
21 Active, not recruiting Allogeneic Neuroblastoma Cells for Relapsed/ Refractory Neuroblastoma, CYCHEALL
Condition: Neuroblastoma
Intervention: Biological: Injection of allogeneic neuroblastoma cells
22 Terminated
Has Results
Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: Temsirolimus;   Drug: Irinotecan;   Procedure: Surgical Resection of Primary Tumor;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Etoposide;   Drug: Cisplatin;   Drug: Topotecan;   Procedure: PBSC;   Radiation: Radiation Therapy;   Drug: 13-cis-retinoic acid
23 Completed Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma
Condition: Neuroblastoma
Intervention: Drug: Interleukin-2
24 Completed Using Gene Modified Neuroblastoma Cells for the Treatment of Relapsed/Refractory Neuroblastoma
Condition: Neuroblastoma
Interventions: Procedure: Skin Biopsy;   Genetic: Gene Modified Neuroblastoma Cells
25 Completed Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: ifosfamide;   Drug: melphalan;   Drug: tretinoin;   Drug: vincristine sulfate;   Drug: vindesine;   Procedure: autologous bone marrow transplantation;   Procedure: conventional surgery;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
26 Unknown  Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Drug: doxorubicin hydrochloride;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate
27 Recruiting Therapy for Children With Advanced Stage Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: cyclophosphamide;   Drug: topotecan;   Biological: hu14.18K322A;   Procedure: peripheral blood stem cell harvest;   Procedure: surgical resection;   Drug: cisplatin;   Drug: etoposide;   Drug: doxorubicin;   Drug: vincristine;   Drug: busulfan;   Drug: melphalan;   Biological: peripheral blood stem cell transplantation;   Biological: natural killer cell infusion;   Radiation: radiation therapy;   Biological: GM-CSF;   Biological: G-CSF;   Drug: mesna;   Drug: levetiracetam;   Biological: interleukin-2;   Drug: Isotretinoin
28 Completed Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: gene-modified tumor cell vaccine therapy;   Biological: interleukin-2 gene
29 Active, not recruiting A Phase I/II Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells
Condition: Neuroblastoma
Intervention: Biological: SJNB-JF-IL2 and SJNB-JF-Lptn cells and SKNLP Unmodified Neuroblastoma Cell Lines
30 Completed Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy
Condition: Neuroblastoma
Intervention: Biological: autologous neuroblastoma vaccine
31 Recruiting Genetic Biomarkers in Children With Neuroblastoma (Also Known as Neuroblastoma Epidemiology in North America [NENA])
Condition: Neuroblastoma
Interventions: Other: laboratory biomarker analysis;   Other: questionnaire administration
32 Unknown  Biomarkers in Samples From Young Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Genetic: polymerase chain reaction;   Genetic: protein expression analysis;   Genetic: western blotting;   Other: flow cytometry;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
33 Unknown  Biomarkers in Young Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Genetic: DNA analysis;   Genetic: DNA methylation analysis;   Genetic: RNA analysis;   Genetic: comparative genomic hybridization;   Genetic: mutation analysis;   Genetic: polymorphism analysis
34 Unknown  Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma
Condition: Neuroblastoma
Interventions: Genetic: RNA analysis;   Genetic: polymerase chain reaction;   Genetic: protein expression analysis;   Genetic: proteomic profiling;   Genetic: western blotting;   Other: enzyme-linked immunosorbent assay;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: liquid chromatography;   Other: mass spectrometry
35 Unknown  Studying Gene Expression in Samples From Younger Patients With Neuroblastoma
Conditions: Neoplastic Syndrome;   Neuroblastoma
Interventions: Genetic: gene expression analysis;   Genetic: protein expression analysis;   Other: enzyme-linked immunosorbent assay;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: medical chart review
36 Unknown  Studying Biomarkers in Samples From Patients With High-Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Genetic: DNA analysis;   Genetic: polymerase chain reaction;   Other: laboratory biomarker analysis;   Other: medical chart review
37 Recruiting Phase II Study of Proton Radiation Therapy for Neuroblastoma
Conditions: Neuroblastoma;   Ganglioneuroblastoma
Intervention: Radiation: Proton Beam Radiation Therapy
38 Completed Multiple Therapies in Treating Patients With Advanced Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Biological: monoclonal antibody 3F8;   Biological: sargramostim;   Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: isotretinoin;   Drug: thiotepa;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate;   Procedure: autologous bone marrow transplantation;   Procedure: bone marrow ablation with stem cell support;   Procedure: conventional surgery;   Procedure: drug resistance inhibition treatment;   Procedure: peripheral blood stem cell transplantation;   Procedure: syngeneic bone marrow transplantation;   Radiation: radiation therapy
39 Completed Combination Chemotherapy or Observation Following Surgery in Treating Infants With Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: vincristine sulfate;   Procedure: conventional surgery
40 Unknown  Gene Expression in Predicting Outcome in Samples From Patients With High-Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Genetic: RNA analysis;   Genetic: gene expression analysis;   Other: laboratory biomarker analysis

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years